Phase I–II trial of doxifluridine (5′DFUR) administered as long-term continuous infusion using a portable infusion pump for advanced colorectal cancer
- 1 November 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (11) , 1543-1548
- https://doi.org/10.1016/0277-5379(89)90295-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- A phase II study of doxifluridine in patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- A randomized comparison of doxifluridine and fluorouracil in colorectal carcinomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Phase II study of 5?-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanomaCancer Chemotherapy and Pharmacology, 1986
- Doxifluridine (5?-dFUrd) in patients with advanced colorectal carcinomaCancer Chemotherapy and Pharmacology, 1985
- Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neckEuropean Journal of Cancer and Clinical Oncology, 1984
- Phase II study of doxifluridine in advanced colorectal adenocarcinoma.Journal of Clinical Oncology, 1983
- Tumor inhibitory effects of a new fluorouracil derivative: 5′-deoxy-5-fluorouridinePublished by Elsevier ,1980
- Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosidesJournal of Medicinal Chemistry, 1979
- Drugs Five Years Later: BleomycinAnnals of Internal Medicine, 1979
- Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinomaCancer, 1975